North America
South America
Australia & New Zealand
Europe
Middle East / Africa
Asia / Pacific
×
×
Purified Mouse Anti-Laminin B2 22/Laminin RUO

Purified Mouse Anti-Laminin B2 

Clone  22/Laminin   (RUO)

  • Brand BD Transduction Laboratories™
  • Concentration 250 µg/ml
  • Isotype Mouse IgG1
  • Reactivity Human (QC Testing)  Rat, Rabbit (Tested in Development) 
  • Application Western blot (Routinely Tested) 
    Bioimaging (Tested During Development) 
  • Immunogen Human Laminin B2 aa. 506-691
  • Storage Buffer Aqueous buffered solution containing BSA, glycerol, and ≤0.09% sodium azide.
  • Regulatory Status RUO
Product Details Recommended Assay References

Description

The basal lamina contains Collagen Type IV, proteoglycans, and glycoproteins. Laminin is a high molecular weight (≈850 kDa) oligomer, consisting of three different chains (A, B1, and B2) joined by disulfide bonds. The overall structure predicts two helical domains (I&II) at the COOH-terminal, cysteine-rich repeats (III&V), and two globular domains (IV&VI). Domains IV and VI are the binding sites for collagen and heparan sulfate, respectively. Several isoforms have been identified for the genes of each chain. Laminin B2 is 1576 amino acids plus a 33 amino acid signal peptide, 14 glycosylation sites, and 12 cysteine repeat domains. The expression of the Laminin subunits is detected rapidly during development and tissue regeneration. Attachment of cells to the basal lamina affects mitogenesis, motility, and differentiation.

Format
  • Format Purified
Suggested Companion Products

FITC Goat Anti-Mouse Ig Polyclonal RUO
0.5 mg Cat No: 554001

HRP Goat Anti-Mouse Ig RUO
1 mL Cat No: 554002

Fixation Buffer RUO
100 mL Cat No: 554655

Perm Buffer III RUO
125 mL Cat No: 558050

Stain Buffer (FBS) RUO
500 mL Cat No: 554656

Resources & Tools
 Spectrum Viewer  Download TDS  Regulatory Document Website
Preparation and Storage

Store undiluted at -20°C. The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography.

Product Notices

  1. Since applications vary, each investigator should titrate the reagent to obtain optimal results.
  2. Please refer to www.bdbiosciences.com/pharmingen/protocols for technical protocols.
  3. This antibody has been developed and certified for the bioimaging application. However, a routine bioimaging test is not performed on every lot. Researchers are encouraged to titrate the reagent for optimal performance.
  4. Caution: Sodium azide yields highly toxic hydrazoic acid under acidic conditions. Dilute azide compounds in running water before discarding to avoid accumulation of potentially explosive deposits in plumbing.
  5. Source of all serum proteins is from USDA inspected abattoirs located in the United States.
  6. Triton is a trademark of the Dow Chemical Company.


Bioimaging

1. Seed the cells in appropriate culture medium at ~10,000 cells per well in a BD Falcon™ 96-well Imaging Plate (Cat. No. 353219) and culture overnight.

2. Remove the culture medium from the wells, and fix the cells by adding 100 μl of BD Cytofix™ Fixation Buffer (Cat. No. 554655) to each well. Incubate for 10 minutes at room temperature (RT).

3. Remove the fixative from the wells, and permeabilize the cells using either BD Perm Buffer III, 90% methanol, or Triton™ X-100:

a. Add 100 μl of -20°C 90% methanol or Perm Buffer III (Cat. No. 558050) to each well and incubate for 5 minutes at RT.

OR

b. Add 100 μl of 0.1% Triton™ X-100 to each well and incubate for 5 minutes at RT.

4. Remove the permeabilization buffer, and wash the wells twice with 100 μl of 1× PBS.

5. Remove the PBS, and block the cells by adding 100 μl of BD Pharmingen™ Stain Buffer (FBS) (Cat. No. 554656) to each well. Incubate for 30 minutes at RT.

6. Remove the blocking buffer and add 50 μl of the optimally titrated primary antibody (diluted in Stain Buffer) to each well, and incubate for 1 hour at RT.

7. Remove the primary antibody, and wash the wells three times with 100 μl of 1× PBS.

8. Remove the PBS, and add the second step reagent at its optimally titrated concentration in 50 μl to each well, and incubate in the dark for 1 hour at RT.

9. Remove the second step reagent, and wash the wells three times with 100 μl of 1× PBS.

10. Remove the PBS, and counter-stain the nuclei by adding 200 μl per well of 2 μg/ml Hoechst 33342 (e.g., Sigma-Aldrich Cat. No. B2261) in 1× PBS to each well at least 15 minutes before imaging.

11. View and analyze the cells on an appropriate imaging instrument.

Bioimaging: For more detailed information please refer to http://www.bdbiosciences.com/support/resources/protocols/ceritifed_reagents.jsp

Western blot: For more detailed information please refer to http://www.bdbiosciences.com/pharmingen/protocols/Western_Blotting.shtml


  1. Engvall E. Laminin variants: why, where and when?. Kidney Int. 1993; 43(1):2-6. View reference

  2. Paroni G, Henderson C, Schneider C, Brancolini C. Caspase-2 can trigger cytochrome C release and apoptosis from the nucleus. J Biol Chem. 2002; 277(17):15147-15161. View reference

  3. Pikkarainen T, Kallunki T, Tryggvason K. Human laminin B2 chain. Comparison of the complete amino acid sequence with the B1 chain reveals variability in sequence homology between different structural domains. J Biol Chem. 1988; 263(14):6751-6758. View reference

  4. Wewer UM, Engvall E, Paulsson M, Yamada Y, Albrechtsen R. Laminin A, B1, B2, S and M subunits in the postnatal rat liver development and after partial hepatectomy. Lab Invest. 1992; 66(3):378-389. View reference

610722 Rev. 3
Instruments
Reagents
Applications
Sales & Support
BD BioSciences